Search

everythinglearnresearchcommunity

for

Search:↓

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

A new compound shows promise as a topical treatment for hair loss.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

The new delivery method for dutasteride is more effective and has fewer side effects.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.